Dr. Michael A. Lee, MD

Dr. Lee practices at Medderm Associates in San Diego, California.

Dr. Lee's NPI, 1255607685, was assigned on March 29, 2012. Dr. Lee graduated from University of Illinois College of Medicine - Chicago in 2012. Dr. Lee's California license number on file is A128109.

Dr. Lee's primary practice is Medderm Associates, at 3965 5th Ave Suite 200 Suite 200, San Diego, CA 92103-3107. The practice phone is (619) 542-0013.

Dr. Lee's primary practice is Medderm Associates in San Diego, California. The medical group on file is MedDerm San Diego Dermatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices. Vendor and product names are available with a free account.

Dermatology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Lee is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Lee's licenses on file in 6 states: California, Florida, Washington, Wisconsin, Texas and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, hives, itchy rashes, psoriasis and scalp rash among the conditions Dr. Lee treats.

CMS data shows 1,980 Medicare services from Dr. Lee across 16 procedure codes in 2024, for 433 Medicare patients. Medicare paid $148,948 for them. Every service was in an office.

CMS counts 433 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 225 patients. 72% of them have high cholesterol, and 59% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 48, with 51% women.

In 2024, Dr. Lee wrote 417 Medicare Part D claims for 202 patients. 93% of them were for generic drugs. CMS names the drug for 282 of them, across 9 drugs with 11 or more claims each, at $7,568 in total drug cost. In 2023, CMS named 320 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Lee for performance year 2024, reported as part of a group. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 664 procedures of removal of skin lesions by Dr. Lee, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Lee. The most frequent topics are Biopsy, Needle, Disease Progression and Endemic Diseases. Dr. Lee has published most often in J Am Acad Dermatol. Dr. Lee's most frequent co-authors are Christopher Paul Downing, MD, Stephen Keith Tyring, MD, PhD and Barry Ladizinski, MD.

CMS Open Payments shows 383 general payments to Dr. Lee from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Bristol-Myers Squibb Company paid the most, $3,599.

Dr. Lee graduated from University of Illinois College of Medicine - Chicago in 2012.

Dr. Lee is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.